cdmo.directory
← Compare landing

Asimov vs Minaris Advanced Therapies

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/asimov/wuxi-advanced-therapies

CategoryAsimovMinaris Advanced Therapies
Listed sitecdmocdmo
SummaryAsimov provides cell line development, upstream process development, and viral vector manufacturing services powered by proprietary synthetic biology platforms (CHO Edge, LV Edge, AAV Edge, RNA Edge) that deliver high-titer, stable cell lines and production systems for biologics, cell therapies, and gene therapies.Pure-play cell and gene therapy CDMO with over 25 years of GMP manufacturing, process development, and biosafety testing expertise. Serves advanced therapy innovators globally from early stage through commercialization.
Services
  • CMC Analytical Development
  • Technology Transfer
  • Lentiviral Vector Manufacturing
  • AAV Manufacturing
  • Viral Vector Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Biologics Development & Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Process Development
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Cell-Line Development
  • Technology Transfer
  • Process Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Quality Control Testing
  • Vaccine Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Gene Therapy
  • Cell Therapy
  • mRNA
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • AAV / Viral Vector Platform
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Boston, MA, USA
  • Headquarters, Philadelphia, PA, United States
  • Philadelphia, Philadelphia, PA, United States
  • Allendale, Allendale, NJ, United States
  • Taufkirchen, Taufkirchen, Bavaria, Germany
  • London, London, England, United Kingdom
  • Yokohama, Yokohama, Kanagawa, Japan
  • Manufacturing & Testing, Philadelphia, PA, United States
  • Manufacturing, Allendale, NJ, United States
  • Manufacturing, Taufkirchen, Bavaria, Germany
  • Office, London, England, United Kingdom
  • Manufacturing, Yokohama, Kanagawa, Japan
  • Manufacturing & Testing, Allendale, NJ, United States
  • Manufacturing & Testing, Taufkirchen, Bavaria, Germany
  • Manufacturing & Testing, Yokohama, Kanagawa, Japan
CertificationsData not yet provided.
  • FDA · Identifier: Commercial manufacturing approval
  • EMA · Identifier: Commercial manufacturing approval
  • PMDA · Identifier: Commercial manufacturing approval
  • FDA · Identifier: FDA approval for commercial manufacturing
  • EMA · Identifier: EMA approval for commercial manufacturing
  • PMDA · Identifier: PMDA approval for commercial manufacturing
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.